COMMUNICATION STYLE: GENTLE (Grade 6-8 reading level) WRITING RULES: - Maximum 15 words per sentence - Use bullet...

Question asked:

COMMUNICATION STYLE: GENTLE (Grade 6-8 reading level) WRITING RULES: - Maximum 15 words per sentence - Use bullet points, not paragraphs - NO medical jargon - use plain language alternatives: • "spread" not "metastasis" • "tissue sample" not "biopsy" • "gene change" not "mutation" • "imaging scan" not "PET-CT" - NO statistics, percentages, or survival numbers - Focus on: what to do next, who to talk to, what questions to ask - Tone: Warm, reassuring, like explaining to a worried family member - Always end with encouragement and clear next steps FORMAT: • Use short bullet points • Bold the most important action items • Include "Questions for your doctor" as simple yes/no questions Five oncology perspectives have analyzed a cancer case: 1. Standard of Care (NCCN guidelines) 2. Emerging Evidence (clinical trials, cutting edge) 3. Molecular/Targeted (precision medicine) 4. Watch & Wait (conservative, de-escalation) 5. Whole Person (quality of life, integrative) Standard of Care: The diagnosis is NOT unknown - this patient has confirmed small cell lung carcinoma (SCLC) with extensive-stage disease. Two separate pathology reports clearly document poorly differentiated carcinoma consistent with small cell carcinoma from the left lower lobe lung mass, with imaging showing widespread metastases to brain, adrenal glands, bones, and other organs. Recommendation: This is confirmed extensive-stage small cell lung carcinoma (ES-SCLC) requiring urgent multidisciplinary care. Immediate priorities per NCCN guidelines: (1) Emergency neurosurgery/radiation oncology consult for symptomatic brain metastases with hemorrhage and hydrocephalus, (2) Medical oncology to initiate platinum-based chemotherapy plus immunotherapy (carboplatin/etoposide + atezolizumab is standard), and (3) Supportive care for symptom management. No additional diagnostic testing needed - treatment should begin urgently given brain involvement. Emerging Evidence: The diagnosis is NOT 'unknown' - this patient has confirmed small cell lung carcinoma (SCLC) with extensive-stage disease (brain, adrenal, bone, and organ metastases). The pathology clearly shows poorly differentiated carcinoma with Ki-67 >90% consistent with SCLC, though TTF-1 and CD56 are atypically negative. Recommendation: **Immediate actions needed**: (1) Confirm final pathology classification with additional neuroendocrine markers (synaptophysin, chromogranin, INSM1) to distinguish pure SCLC vs. combined histology, (2) Urgent neuro-oncology consult for brain metastases management (WBRT vs. SRS), (3) Initiate platinum-etoposide-immunotherapy within days given extensive disease and high Ki-67, (4) Consider enrollment in trials combining novel agents like tarlatamab (NCT05740566) or PARP inhibitors with chemotherapy for extensive-stage SCLC at NCI-designated center. Molecular/Targeted: The diagnosis is NOT unknown - your records clearly show small cell lung cancer that has spread to your brain and other organs. Two separate tissue tests confirmed small cell carcinoma from your left lung mass. The cancer has metastasized extensively based on PET/CT and brain imaging. Recommendation: **You need immediate oncology care for Stage IV small cell lung cancer.** Ask your oncologist: 1) Should I start chemotherapy right away? 2) Do I need brain radiation for the bleeding brain tumors? 3) What gene tests should be done on my tumor sample? Small cell lung cancer grows very fast but often responds well to treatment initially. Watch & Wait: The diagnosis is NOT 'unknown' - your records clearly show small cell lung cancer that has spread to your brain and other organs. This is a confirmed diagnosis from tissue samples and imaging scans. The cancer is advanced but has a clear treatment path. Recommendation: Your diagnosis IS complete and confirmed as Stage IV small cell lung cancer. The key question now is whether aggressive treatment or comfort-focused care aligns with your goals, given the extensive spread. You need an urgent discussion with your oncologist about treatment options versus quality-of-life focused care. Whole Person: The diagnosis is NOT 'unknown' - this patient has confirmed small cell lung cancer (SCLC) with extensive brain metastases. The pathology clearly shows poorly differentiated carcinoma consistent with small cell carcinoma from the left lung, with very aggressive features (Ki-67 >90%). This is Stage IV extensive-stage disease requiring urgent treatment. Recommendation: The diagnosis is complete and correct: extensive-stage small cell lung cancer (Stage IV) with brain, adrenal, bone, and organ metastases. Immediate priorities are: 1) Start chemotherapy urgently (carboplatin/etoposide is standard), 2) Brain radiation for bleeding metastases and symptom control, 3) Manage brain swelling with steroids, and 4) Palliative care consultation NOW to help with symptoms and quality of life during treatment. SCLC responds well initially to treatment, so starting quickly matters. Synthesize ALL FIVE perspectives. Respond in this exact JSON format: { "headline": "One sentence (max 15 words) in plain language summarizing the key finding", "bullets": ["Key point 1 in plain language", "Key point 2", "Key point 3"], "consensus": ["Point where perspectives agree, in plain language"], "divergence": ["Where perspectives differ, explained simply"] } - The "headline" field is the most important - make it actionable and clear - Be specific about which perspectives agree or disagree - Focus on what the patient should discuss with their oncologist